基于网络药理学的罗格列酮复方作用机制探讨

The mechanism of rosiglitazone compound based on network pharmacology

在新药研发及药理学研究领域,网络药理学的应用日渐广泛,方法层出不穷。本研究以罗格列酮复方为研究对象,采用3种网络药理学预测方法进行靶点预测和作用机制探讨,并比较评价3种预测方法的异同。研究发现,3种方法预测得到的结果并不相同,但钙信号转导通路在3种方法中均可预测到。经生物信息学分析发现,这条通路与糖尿病及糖尿病引起的认知障碍相关,表明钙信号转导通路是罗格列酮复方作用过程中重要的信号调节通路。本研究为该复方作用机制的进一步阐释提供了线索,同时也为实际研究中网络药理学靶点预测方法的选择和应用提供参考。

Applications of network pharmacology are increasingly widespread and methods abound in the field of drug development and pharmacological research. In this study, we choose rosiglitazone compound as the object to predict the targets and to discuss the mechanism based on three kinds of prediction methods of network pharmacology. Comparison of the prediction result has identified that the three kinds of prediction methods had their own characteristics： targets and pathways predicted were not in accordance with each other. However, the calcium signaling pathway could be predicted in the three kinds of methods, which associated with diabetes and cognitive impairment caused by diabetes by bioinformatics analysis. The above conclusion indicates that the calcium signaling pathway is important in signal pathway regulation of rosiglitazone compound, which provides a clue to further explain the mechanism of the compound and also provides a reference for the selection and application of methods of network pharmacology in the actual research.